SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SB-2
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
- -------------------------------------------------------------------------------
CROSS GENETIC TECHNOLOGIES, INC.
(Name of small business issuer in its charter)
Virginia 541511 54-203-0708
- -------------------------------------------------------------------------------
(State of Incorporation) (Primary Standard (IRS Employer I.D. Number)
Industrial Classification
Number)
11921 Freedom Drive, Suite 550, Reston, VA 20190 (703) 925-5912
- -------------------------------------------------------------------------------
(Address and telephone number of principal executive offices)
11921 Freedom Drive, Suite 550, Reston, VA 20190
- -------------------------------------------------------------------------------
(Address of principal place of business)
McSweeney & Crump, P.C., 11 South 12th Street, 5th Floor, Richmond, VA 23219
- -------------------------------------------------------------------------------
(Name, address and telephone number of agent for service)
Approximate date of proposed commencement of sale to the public: From
time to time after the Registration Statement becomes effective.
CALCULATION OF REGISTRATION FEE
Title of each class of Amount of Shares Proposed maximum Proposed Maximum Amount of
Securities to be registered to be registered offer price per unit aggregate offering price registration fee
Common stock 11,008,000 $0.05 $550,400 $137.60
The registrant hereby amends this registration statement on such date or dates
as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement
shall thereafter become effective in accordance with Section 8(a) of the
Securities Act of 1933 or until the registration statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.